Product nameAnti-EXOSC5 antibody
See all EXOSC5 primary antibodies
DescriptionRabbit polyclonal to EXOSC5
Tested applicationsSuitable for: WB, IPmore details
Species reactivityReacts with: Human
Synthetic peptide, corresponding to a region within amino acids 1-50 of Human EXOSC5 (NP_064543.3, Uniprot: Q9NQT4)
- 293T, HeLa and Jurkat cell lysates.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: 99% Tris citrate/phosphate
pH 7 to 8
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab168804 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/2000 - 1/10000. Predicted molecular weight: 25 kDa.|
|IP||Use at 2-10 µg/mg of lysate.|
FunctionNon-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as anti-sense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes.
Tissue specificityHighly expressed in a variety of hematopoietic and epithelial tumor cell lines, but not in normal hematopoietic tissues or other normal tissue, with the exception of testis.
Sequence similaritiesBelongs to the RNase PH family.
Cellular localizationNucleus > nucleolus. Cytoplasm. Nucleus.
- Information by UniProt
- Chronic myelogenous leukemia tumor antigen 28 antibody
- CML28 antibody
- EXOS5_HUMAN antibody
Immunoprecipitation analysis of whole cell lysate (1 mg for IP; 20% of IP loaded) from 293T cells. 1) ab168804 (6 µg/mg lysate). 2) A rabbit anti-EXOSC5 antibody immunoprecipitated EXOSC5. 3) Control IgG. For blotting ab168804 was used at 1 µg/ml. Detection by chemiluminescence with an exposure time of 10 seconds.
All lanes : Anti-EXOSC5 antibody (ab168804) at 0.1 µg/ml
Lane 1 : 293T cell lysate at 50 µg
Lane 2 : 293T cell lysate at 15 µg
Lane 3 : HeLa cell lysate at 50 µg
Lane 4 : Jurkat cell lysate at 50 µg
Developed using the ECL technique.
Predicted band size: 25 kDa
Exposure time: 3 minutes
This product has been referenced in:
- Chiu HP et al. Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein. PLoS Pathog 14:e1007166 (2018). Read more (PubMed: 30016363) »
- Lima WF et al. RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery. Nucleic Acids Res 44:3351-63 (2016). WB ; Human . Read more (PubMed: 26843429) »